Digital Therapeutics Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to digital therapeutics market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Digital Therapeutics Market News

in Digital Therapeutics Market
  • In May 2024, Otsuka announced the introduction of their subsidiary focusing on data and technology. The Otsuka Precision Health will commercialize Rejoyn, which is a digital therapeutic for people suffering from major depressive disorder.
  • In January 2024, Eli Lilly and Company introduced their LillyDirect. It is a digital healthcare platform for U.S. patients that can manage obesity, migraine, and diabetes.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Digital Therapeutics Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 8.21 billion in 2024 to USD 53.15 billion by 2032, growing at a CAGR of 26.3% during the forecast period (2025-2032).

Dassault Systemes (SIMULIA), PTC (Creo), Autodesk (Simulation), ESI Group, MathWorks (MATLAB/Simulink), Flow3D, Cadence Design Systems, Synopsys, Teladoc Health Inc., 2Morrow, Inc., Canary Health, Click Therapeutics Inc., Akili, Inc., Cognoa Inc., Twill Inc., Kaia Health, BehaVR Inc., Ayogo, Mindable Health GmbH, Orexo AB.

The demand for therapeutics software and devices is increasing because of the management and treatment of chronic diseases globally. Furthermore, the incidences of chronic conditions, like type 1 diabetes & type 2 diabetes, cancers, Alzheimer’s diseases, obesity, and gastrointestinal disorders are also increasing. This is especially true in emerging economies, which is propelling the demand for this software during the forecast period.

Digital therapeutics can be smoothly incorporated into electronic health records (EHRs) and other healthcare systems. This helps medical professionals to easily access and monitor patient data in real-time. This restructuring of medical delivery enhances the efficiency of care and helps doctors to make better and more informed decisions. Furthermore, incorporation with medical systems also improves security and standardizes data sharing between digital therapeutics platforms and medical professionals.

North America contributed the most with around 41% of worldwide revenue. This is due to a variety of reasons, including increased use of digital health devices and beneficial reimbursement scenarios that emphasize improving quality of life through improved tracking and diagnostics. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Digital Therapeutics Market Report by SkyQuest Technology
Digital Therapeutics Market

Report ID: SQMIG35G2136

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE